We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Mark Tang is a managing director of Good Health Capital, New York, a healthcare private equity firm with offices in Asia and New York. Mark has over two decades of experience in the field of biotechnology as an entrepreneur, biotech investment banker, educator, advisor and investor. He worked at PaineWebber/UBS and Morgan Stanley Dean Witter. He was formerly a research associate at Rockefeller University and biotech director at Rutgers Business School. Mark holds an MBA from NYU Stern School and an MPH from Harvard Chan School.
This speaker's sessions: